These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 18922583)

  • 1. Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.
    Lafuente A; Bernardo M; Mas S; Crescenti A; Aparici M; Gasso P; Deulofeu R; Mane A; Catalan R; Carne X
    Psychiatry Res; 2008 Nov; 161(2):131-41. PubMed ID: 18922583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol.
    Zivković M; Mihaljević-Peles A; Bozina N; Sagud M; Nikolac-Perkovic M; Vuksan-Cusa B; Muck-Seler D
    J Clin Psychopharmacol; 2013 Oct; 33(5):593-9. PubMed ID: 23963056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between adverse effects of antipsychotic treatment and dopamine D(2) receptor polymorphisms in patients with schizophrenia.
    Kaiser R; Tremblay PB; Klufmöller F; Roots I; Brockmöller J
    Mol Psychiatry; 2002; 7(7):695-705. PubMed ID: 12192613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone.
    Yamanouchi Y; Iwata N; Suzuki T; Kitajima T; Ikeda M; Ozaki N
    Pharmacogenomics J; 2003; 3(6):356-61. PubMed ID: 14610521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of DRD2 polymorphisms and chlorpromazine-induced extrapyramidal syndrome in Chinese schizophrenic patients.
    Wu SN; Gao R; Xing QH; Li HF; Shen YF; Gu NF; Feng GY; He L
    Acta Pharmacol Sin; 2006 Aug; 27(8):966-70. PubMed ID: 16867246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141C Ins/Del polymorphisms.
    Himei A; Koh J; Sakai J; Inada Y; Akabame K; Yoneda H
    Psychiatry Clin Neurosci; 2002 Feb; 56(1):97-102. PubMed ID: 11929577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms.
    Gassó P; Mas S; Bernardo M; Alvarez S; Parellada E; Lafuente A
    Pharmacogenomics J; 2009 Dec; 9(6):404-10. PubMed ID: 19506579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family-based and case-control study of DRD2, DAT, 5HTT, COMT genes polymorphisms in alcohol dependence.
    Samochowiec J; Kucharska-Mazur J; Grzywacz A; Jabłoński M; Rommelspacher H; Samochowiec A; Sznabowicz M; Horodnicki J; Sagan L; Pełka-Wysiecka J
    Neurosci Lett; 2006 Dec; 410(1):1-5. PubMed ID: 17079080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Family based association study of DRD1, DRD2, DRD3, DRD4, DAT, COMT gene polymorphism in schizophrenia].
    Paweł K; Hauser J; Skibińska M; Szczepankiewicz A; Dmitrzak-Weglarz M; Gorzkowska K; Pawlak J; Czerski PM
    Psychiatr Pol; 2010; 44(3):405-13. PubMed ID: 20672519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients.
    Wu S; Xing Q; Gao R; Li X; Gu N; Feng G; He L
    Neurosci Lett; 2005 Mar; 376(1):1-4. PubMed ID: 15694263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [No association of 141C-ins/del polymorphism in the D2 dopamine receptor gene in schizophrenia].
    Rohrmeier T; Putzhammer A; Sartor H; Knapp M; Albus M; Borrmann-Hassenbach M; Lichtermann D; Wildenauer D; Schwab S; Maier W; Klein HE; Eichhammer P
    Psychiatr Prax; 2003 May; 30 Suppl 2():S212-5. PubMed ID: 14509080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between neuroleptic drug-induced extrapyramidal symptoms and dopamine D2-receptor polymorphisms in Japanese schizophrenic patients.
    Nakazono Y; Abe H; Murakami H; Koyabu N; Isaka Y; Nemoto Y; Murata S; Tsutsumi Y; Ohtani H; Sawada Y
    Int J Clin Pharmacol Ther; 2005 Apr; 43(4):163-71. PubMed ID: 15966462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment.
    Molero P; Ortuño F; Zalacain M; Patiño-García A
    Pharmacogenomics J; 2007 Dec; 7(6):418-26. PubMed ID: 17363961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of DRD2 polymorphisms on the clinical outcomes of patients with schizophrenia.
    Zahari Z; Teh LK; Ismail R; Razali SM
    Psychiatr Genet; 2011 Aug; 21(4):183-9. PubMed ID: 21206399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine metabolism in adults with 22q11 deletion syndrome, with and without schizophrenia--relationship with COMT Val¹⁰⁸/¹⁵⁸Met polymorphism, gender and symptomatology.
    Boot E; Booij J; Abeling N; Meijer J; da Silva Alves F; Zinkstok J; Baas F; Linszen D; van Amelsvoort T
    J Psychopharmacol; 2011 Jul; 25(7):888-95. PubMed ID: 21447540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia.
    Matsumoto C; Shinkai T; Hori H; Ohmori O; Nakamura J
    Psychiatry Res; 2004 Jun; 127(1-2):1-7. PubMed ID: 15261699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insertion/deletion variant (-141C Ins/Del) in the 5' regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder. Short communication.
    Stöber G; Jatzke S; Heils A; Jungkunz G; Knapp M; Mössner R; Riederer P; Lesch KP
    J Neural Transm (Vienna); 1998; 105(1):101-9. PubMed ID: 9588764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women.
    Sazci A; Ergul E; Kucukali I; Kilic G; Kaya G; Kara I
    Brain Res Mol Brain Res; 2004 Dec; 132(1):51-6. PubMed ID: 15548428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The COMT and DRD3 genes interacted in bipolar I but not bipolar II disorder.
    Lee SY; Chen SL; Chen SH; Huang SY; Tzeng NS; Chang YH; Wang CL; Lee IH; Yeh TL; Yang YK; Lu RB
    World J Biol Psychiatry; 2011 Aug; 12(5):385-91. PubMed ID: 20698735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of COMT H108L, MAOB int 13 A>G and DRD2 haplotype on the susceptibility to Parkinson's disease in South Indian subjects.
    Kumudini N; Umai A; Devi YP; Naushad SM; Mridula R; Borgohain R; Kutala VK
    Indian J Biochem Biophys; 2013 Oct; 50(5):436-41. PubMed ID: 24772965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.